U.S. senator wants to know how the FDA will enforce drug ad regulations after letting go numerous workers from the office ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Scientists are probing woolly mammoth and Neanderthal genetic codes for new compounds as today’s drugs lose potency.

The institute, in its release, said that the multidisciplinary investigation into the issue revealed the potential of ...

The researchers focused on CymAKp, a dynamic porin found in Klebsiella pneumoniae, a WHO-listed high-priority pathogen. Using ...

The British drugmaker may have succeeded in reviving an oral antibiotic previously rejected by the FDA when it was under development at Spero.

GSK and Spero ended a Phase 3 trial early meeting efficacy goals in cUTIs, positioning its treatment as the first oral ...

Tech oligarchs’ wildest visions of tomorrow amount to a modern secular theology that is both mesmerizing and, in his view, ...

Microalgae of the species Monoraphidium contortum have the ability to remove antibiotic residues from water, especially ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter ...

Using neem tree extracts as a starting point, scientists have created several kinds of nanozymes and tested them for ...